CureVac - Ingmar Hoerr, CEO

Pinanood ng 1,217 beses

Pagpapatunay ng katauhan

8.1
Salamat, ang boto mo ay nairekord na at malapit ng makita.
Oo
Hindi
Idinagdag sa iyong profile favorites.
Paglalarawan ng bidyo:

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

Mga Komento